| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0081 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0053 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |